Bing Zheng

Therapeutic potential of an anti-CD79b antibody–drug conjugate, anti–CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma

David Dornan, Fiona Bennett, Yvonne Chen et al. · Blood · 2009 · 271 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection

Andrew G. Polson, Jill Calemine-Fenaux, Pamela Chan et al. · Cancer Research · 2009 · 249 citations

Medicine, Oncology, Pharmacology +17

Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma

Andrew G. Polson, Shang‐Fan Yu, Kristi Elkins et al. · Blood · 2007 · 172 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs

Shang‐Fan Yu, Bing Zheng, MaryAnn Go et al. · Clinical Cancer Research · 2015 · 162 citations

Medicine, Oncology, Pharmacology +17

An anti-CD3/anti–CLL-1 bispecific antibody for the treatment of acute myeloid leukemia

Steven R. Leong, Siddharth Sukumaran, Maria Hristopoulos et al. · Blood · 2016 · 153 citations · Full text

Medicine, Hematology, Oncology +14